Home » Topics » Disease categories and therapies » Hematologic

Hematologic
RSS

Synthesis and use of factor Xa inhibitors described in patent by Lilly

April 16, 2002

Anticoagulants acting via inhibition of thrombin designed at AstraZeneca

April 16, 2002

New BASF compounds for vitronectin-related disorders

April 10, 2002

FDA approves new indication for argatroban

April 10, 2002

Novel factor VIIa inhibitors reported in recent patent

April 8, 2002

AJW-200 exerts a sustained antiplatelet effect without excessive bleeding in primates

April 5, 2002

Shire files for European approval of Xagrid

April 3, 2002

Nycomed signs deal to become exclusive distributor of Angiomax in 35 countries

April 3, 2002

New class of TAFI inhibitors described by Pfizer particularly for promoting fibrinolysis

April 3, 2002

BB-10153 cleared to enter phase II trial

April 2, 2002

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 28, 2026.
Detecting the invisible: minimal residual disease at AACR 2026
BioWorld Science
Minimal residual disease (MRD) has become a central concept in modern oncology, reshaping how clinicians evaluate response, relapse risk and treatment precision....
News in brief
BioWorld Asia
BioWorld Asia briefs for April 28, 2026
Sichuan Kelun Pharmaceutical Research Institute discovers GPR6 inverse agonists
BioWorld Science
Sichuan Kelun Pharmaceutical Research Institute Co. Ltd. has identified G protein-coupled receptor 6 (GPR6) inverse agonists reported to be useful for the...
Grace Therapeutics hits CRL setback with GTx-104 despite positive trial
BioWorld
Grace Therapeutics Inc.’s hopes of becoming the first company in decades to update the standard of care in aneurysmal subarachnoid hemorrhage were delayed after...